[Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene].
Tereshchenko
S N
SN
Dzhaiani
N A
NA
Moiseev
V S
VS
Nosikov
V V
VV
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003971:Diastole; D004452:Echocardiography; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D020913:Perindopril / Q000494:pharmacology* / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D012307:Risk Factors; D013599:Systole; D016277:Ventricular Function, Left / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007703:Peptidyl-Dipeptidase A; D020913:Perindopril